Stay updated on Isatuximab/Len in MRD+ MM Clinical Trial

Sign up to get notified when there's something new on the Isatuximab/Len in MRD+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab/Len in MRD+ MM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study sponsor’s name was updated from “University of Illinois at Chicago” to “University of Illinois Chicago.”
    Difference
    0.3%
    Check dated 2026-10-30T05:57:07.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the clinical trial record.
    Difference
    0.7%
    Check dated 2026-10-23T03:28:35.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-16T08:30:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-09T06:58:22.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The 'Find Contact Information' label was standardized to 'Find contact information', and the page revision badge updated from v3.6.6 to v3.7.0, reflecting a new build.
    Difference
    0.2%
    Check dated 2026-09-18T07:52:56.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The study history adds a new entry on 2026-08-28 for Study Status and a 2026-08-25 addition of '12', while an older 2026-02-23 entry was deleted, reflecting updates to the record's status and version history.
    Difference
    0.4%
    Check dated 2026-09-04T08:42:20.000Z thumbnail image

Stay in the know with updates to Isatuximab/Len in MRD+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab/Len in MRD+ MM Clinical Trial page.